AFX Endovascular AAA System BA25-80/I16-55Recalls & reported problems
Endologix LLC · Class 3 · Implant
All models of AFX Endovascular AAA System (48)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 1
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00818009010070), received between Mar 18, 2016 and Jan 28, 2021 — classified as 1 death, 4 injuries.
The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (2 reports).
16 other recalls cover devices cleared under the same FDA submission (P040002); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Improper or Incorrect Procedure or Method2
- Insufficient Device Problem Information2
- Material Puncture/Hole2
- Use of Device Problem2
- Adverse Event Without Identified Device or Use Problem1
- Deformation Due to Compressive Stress1
- Failure To Adhere Or Bond1
- Migration1
Patient problems
- Failure of Implant4
- Rupture2
- Aneurysm1
- Death1
- No Information1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryJan 28, 2021Material Puncture/Hole; Material Puncture/Hole
THE PATIENT WAS INITIALLY IMPLANTED WITH A BIFURCATED STENT GRAFT AND A SUPRARENAL AORTIC EXTENSION TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY FIVE (5) YEARS POST INITIAL PROCEDURE, THE PATIENT PRESENTED TO THE EMERGENCY ROOM WITH A RUPTURE CAUSED BY A TYPE 3B ENDOLEAK. A SECONDARY PROCEDURE WAS COMPLETED. THE PHYSICIAN ELECTED TO RELINE THE ORIGINAL IMPLANTED DEVICES WITH ANOTHER BIFURCATED STENT GRAFT, A NON- ENDOLOGIX (GORE) LIMB STENT GRAFT AND ANOTHER NON- ENDOLOGIX (ICAST) STENT. THE 3B ENDOLEAK WAS RESOLVED; HOWEVER, THE PATIENT'S BLOOD PRESSURE WAS STILL NOT GOOD BECAUSE OF THE BLOOD IN THE ABDOMEN. THE PHYSICIAN ELECTED TO OPEN THE ABDOMEN TO RELIEVE THE PRESSURE AND MAKE SURE THE GRAFT WAS WORKING TO EXCLUDE THE RUPTURED AAA. THE PATIENT WAS CLOSED AND SENT TO THE INTENSIVE CARE UNIT.
Patient problems: Failure of Implant; Rupture
MAUDE report 11245773 ↗InjuryFeb 24, 2020Use of Device Problem; Improper or Incorrect Procedure or Method; Patient-Device Incompatibility; Deformation Due to Compressive Stress; Insufficient Device Problem Information; Use of Device Problem; Improper or Incorrect Procedure or Method; Patient-Device Incompatibility; Deformation Due to Compressive Stress; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH A BIFURCATED STENT GRAFT, A SUPRARENAL STENT GRAFT EXTENSION AND A LIMB STENT GRAFT EXTENSION TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY 4.5 YEARS POST INITIAL PROCEDURE, THE PATIENT PRESENTED EMERGENTLY WITH A RUPTURED AAA. THE PHYSICIAN ELECTED TO TREAT THE PATIENT WITH A COOK ZENITH (NON-ENDOLOGIX) STENT. THE PATIENT WAS REPORTED AS STABLE AND IS RECOVERING. ADDITIONAL INFORMATION: DURING CLINICAL ASSESSMENT, SAC GROWTH OF 11.9MM, BUCKLING OF THE PROXIMAL EXTENSION, A TYPE IIIB ENDOLEAK OF THE BIFURCATED STENT GRAFT, AND A TYPE IIIA ENDOLEAK OF THE AORTIC COMPONENTS OCCURRED THAT WAS NOT INCLUDED IN THE EVENT AS REPORTED.
Patient problems: Aneurysm; Failure of Implant; Rupture
MAUDE report 9747087 ↗InjuryFeb 14, 2020Material Puncture/Hole; Use of Device Problem; Improper or Incorrect Procedure or Method; Insufficient Device Problem Information; Migration; Material Puncture/Hole; Use of Device Problem; Improper or Incorrect Procedure or Method; Insufficient Device Problem Information; Migration
THE PATIENT WAS INITIALLY IMPLANTED WITH A BIFURCATED STENT GRAFT, A SUPRARENAL STENT GRAFT EXTENSION AND AN INFRARENAL STENT GRAFT EXTENSION TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). APPROXIMATELY FOUR (4) YEARS POST INITIAL PROCEDURE, THE PATIENT PRESENTED AT ROUTINE FOLLOW-UP WITH A MIGRATED (BY 20MM) PROXIMAL STENT GRAFT EXTENSION AND A TYPE 3B ENDOLEAK OF THE BIFURCATED STENT GRAFT. A RE-INTERVENTION WAS PERFORMED. THE PHYSICIAN ELECTED TO RELINE THE ORIGINAL IMPLANTED DEVICES WITH OVATION IX ABDOMINAL STENT GRAFT SYSTEM (ONE MAIN BODY AND 4 ILIAC LIMBS) TO RESOLVE THIS EVENT. THE PATIENT WAS REPORTED AS DOING WELL.
Patient problems: Failure of Implant
MAUDE report 9714952 ↗InjuryApr 19, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2015, THE PATIENT WAS IMPLANTED WITH A BIFURCATED STENT GRAFT, TWO VELA INFRARENALS, AND TWO LIMB STENT GRAFTS (IMPLANTING PHYSICIAN DR. (B)(6)). ON (B)(6) 2016, A SECONDARY PROCEDURE WAS PERFORMED FOR AN UNKNOWN REASON AND THE PATIENT WAS IMPLANTED WITH THREE ADDITIONAL LIMB STENT GRAFTS (IMPLANTING PHYSICIAN (B)(6)). NO ADDITIONAL EVENT OR PATIENT INFORMATION IS AVAILABLE.
Patient problems: No Information
MAUDE report 7443040 ↗DeathMar 18, 2016Failure To Adhere Or Bond; Failure To Adhere Or Bond
PATIENT INITIALLY IMPLANTED WITH A BIFURCATED STENT AND A LIMB EXTENSION ON (B)(6) 2016. INITIAL IMPLANT OF THE STENT WAS DUE TO EMERGENT RUPTURE OF THE ILIAC ARTERY. A FOLLOW UP FOUND THE PATIENT HAD A TYPE 3A ENDOLEAK, THE PHYSICIAN ELECTED TO IMPLANT TWO ADDITIONAL LIMB EXTENSIONS TO SEAL THE ENDOLEAK. PATIENT PROCEDURE WAS SUCCESSFUL, PATIENT CONDITION IS UNSTABLE DUE TO EXISTING DISEASE PROGRESSION. AN UPDATE RECEIVED ON (B)(6) 2016 INDICATED THE PATIENT HAD EXPIRED. ACTUAL PATIENT DATE OF DEATH IS UNKNOWN.
Patient problems: Death; Failure of Implant
MAUDE report 5510955 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P040002. One submission often covers many models, so check the product and lot details in each record.
- Z-1048-2017 · Jan 4, 2017 · TerminatedAFX Endovascular AAA System Item Number Item Description F0070305 A2525/C75 V F0070308 A2828/C75 V F0070312 A3434/C
- Z-1049-2017 · Jan 4, 2017 · TerminatedAFX2 Endovascular AAA System Item No. Item Description F00820-01 BEA28-120/I20-40 F00820-02 BEA28-100/I20-40 F00820-03 BEA28-80/I20-40 F00820-06 BEA28-120/I16-40 F00820-07 B
- Z-1039-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type: IIIB Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
- Z-1037-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIA Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
- Z-1047-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIA Product Usage: The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoili
- Z-1054-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIB Common Name: AFX Bifurcated and Accessory Stent Grafts Classification Name: System, Endovascular Graft, Aortic Aneurysm Treatment
- Z-1035-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIA
- Z-1038-2017 · Dec 27, 2016 · TerminatedAFX Endovascular AAA System, Endoleak Type IIIB; The AFX Endovascular AAA System is intended for endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms (A
- Z-0589-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-140BL
- Z-0596-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-155BL
- Z-0595-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-140BL
- Z-0591-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-135BL
- Z-0592-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-140BL
- Z-0593-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 25-16-155BL
- Z-0594-06 · Dec 14, 2005 · TerminatedPowerlink System for Abdominal Aortic Aneurysm (Endoluminal Bifurcated Prosthesis with Delivery System) Model No. 28-16-135BL
…and 1 more.
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page